balance balance reached underwritten In let’s cash highlights public in an today. significantly X, everyone, our million XXXX joining call turn Please net in to starting sheet. cover $XX.X sheet. position. thanks the with ended few and proceeds cash for $XX.X a Hello, which we Lynne. We offering, in financial strengthened December, million and with the Thanks, Slide our
for million. XXXX cash We the the in was guidance $X.X $XXX,XXX our SEC million, approximately million, $X the full-year $X.X including Net full-year in estimated costs. usage million $X.X which for offering the of press underlying XXXX securities of restructuring usage within and filings. final Additional first-half be operating details of and net year release cash was on the the to our are for available million to payments $X range will
budgeted have just well this in as field an as program, a increase We the greater of evaluation an potential R&D of year spend test number traits. for yield expanded
identify the in ways infrastructure We down to on made building expect costs progress to to continue certain bring XXXX.
technology support expected are under that operations continuing Our cash to our with the review will a operations. On as reported grants current P&L, number into together on mid-XXXX. results revenue government financial hand our of proof let’s points
a loss Full-year $X.XX million, the million associated loss a applicable offering. share. December net shares XXXX, $X.X of a dividend the For includes with full-year per we of shareholders deemed operations issuance or the Series preferred to $XX.X A in related continuing adjustments the to the from reported from common net accounting
reported $X.X million in grant R&D in For $X.X $XXX,XXX expense full-year G&A and we XXXX, million in expense. revenue,
or we $XXX,XXX, deemed million reported $X $X.X In fourth the share, XXXX, of dividend. R&D to charge in applicable a of net we quarter fourth reported revenue the the loss and million $X.XX G&A related common For million, shareholders grant quarter, includes of expense in a to which per $X.X expense.
our on earnings the release. please details financial For refer more to results,
leader and land, accomplishments. for we of solid Slide in gene feed program X, agreement in The CXXXX of to developing and needed were a preparations to has lower the resources inputs combination soybean. term granted progress to trait throughout the fertilizer. do test higher our In food soybean traits evaluate their to recent alone Canola. of beyond the the Monsanto was of CXXXX to This traits as of is evaluation in-house. in world-class biotech program. water test completion fourth for well CXXXX and Monsanto well in for with produce research development YieldXX turn test and The time and program on quarter YieldXX commercialization proprietary produce XXXX. of made test The is We constructs consistent lines. of soybean new a yields with nonexclusive license and X.X-year goals to into what field results a field are can December, a and let’s the Monsanto CXXXX crops XXXX CXXXX for Now encouraging technologies a highlight with and test Camelina and we’re scale in events soybean.
outline During Kristi and our call, data XXXX. summary for our XXXX of a the plans will present
third More the Turning recently, by series while In complete to this a of Camelina is slide. we editing. a a We CXXXX. to an from plan deemed on more and traits license the of combination, seeds in-license XXXX, In our we trait XXXX, took In CXXXXa, University and this accomplishment editing to CXXXX, traits CXXXXb a we genome produce triple option Missouri we’ve trait USDA-FAS genome to completed agency. year. confirmation and oil the focus we edited that CXXXX. in related CXXXX early named nonregulated from genome September, of assembled with on received and
We has made to which for XXXX XXXX. is progress well us very Let’s now positioned in for solid Slide turn well-positioned X. YieldXX XXXX.
assemble a opportunity to proposition rich for of create ag traits is alike. compelling tiers a and to objective Our market value pipeline and growers yield
through in are deploying We our studies. and commercial field conducted proof resources greenhouse to in on points traits our R&D focused the with crops key generate and tests
field to and in our for make genome in proof activities path traits. test with enable U.S. on a for opportunities based edited interest points us. XXXX to and to for our believe, We create cost-effective generating submissions licensees USDA-APHIS the collaborations traits will plan also planed We
X, Let’s now Slide of pipeline turn to trait.
traits of we have Here a our summary development. in
In and to expect be further proof may generate Camelina, CXXXX in our The soybean. that trait complement current acreage in focus We its to have will GMO such gene we regulated as additional yield the is them to CXXXX points CXXXX deploy performance. traits and seed trait XXXX, crops. for increase Canola CXXXX large
a pipeline that which to have of into categories. editing, fit may We traits two we develop be genome using able additional
Our We CXXXX of and very factors are improve CXXXXb, addition been right. then have of oil traits editing transcription CXXXX for CXXXXa, these number instrumental begin crop combinations enhancing identifying of genome in CXXXX. own genes their the have us a performance. transcription and in to the to series But in CXXXX, factor and enabling exciting
these our demonstrate partnerships to opportunities see and the platforms. technology proposition the we of licensing as for key of providing our revenue is services ag for value R&D generate we by Our this objective Across platform all sector. traits areas,
and such can the traits is turn Let’s now to the creation X, then there example American model. slide, the an based change for illustrative have to If yields, this our opportunity harvest. soybean yield the canola, gene YieldXX, company crop in YieldXX. On revenue XXXX value an traits to for we annual grower, seed significant of Slide gene opportunity North produce on to accrue and value corn,
crop. potential increase oil soybean, million the of high for directly which the a there’s yield is XXX such content bringing at increase, would the commodity potential about look you a the further see economic as to deploy this oils market crop. editing an XX% Further the seed, to innovator the revenue traits to increase potential there soybean, of annual model, genome yield we as as nutritional value from increase demand to If
treat average DNA editing and enabling and X, Let’s now trace precision $XXX average A plants, yield into enhancing for global of to just Genome XX will value years nonregulated, does may ag. an this by cost foreign the Slide turn and in USDA development typical product of an completes Thus, editing develop cost. editing GMO combinations. for reducing genome of crop editing regulated – genome take trait box support million introduce using the tool full not significantly deregulation. timelines gene
the capability. combinations announcement that Some by the the targets, cost for editing their estimate form We they This DuPont and through that new market years is innovators. $XX encouraging. is well space to we’ll Pioneer a small performance. the anticipate suggest could the by licenses in gene and Editing genome wait editing unfolds. of see available make editing Broad with to had series Institute than of YieldXX development less Targets as the take An genome the low But six discovery that to have opens improve to that race hasn’t of as as nonexclusive plan be gene identify for Smart in little novel as have CRISPR/CasX crop to development three trait in ag timeline million. powerful new using as as IP that we traits how readily development
targets many covering As in discovery you’ll we our are Kristi’s platform. today, presentation on see based
X, now commercial Let’s strategy. Slide turn the to
potential yield development by in Our to revenue, traits traits multiple with driven paths provide capabilities. and us unique our
commodity can North we as major crops, American soon we working through ag possible majors. Our the as accelerate think, development
germplasm Our deploying is our begin gain and them in technical testing hurdle provide to to resources. sufficient approach their interest and for to their data using develop a low traits then elite
see license genome going to payments path Monsanto approach crops, on taken economics. stack to is in opportunities improve exactly JV-type path specialty specialty traits envisaged improve with in The soybean. This nonregulated innovation have edited composition. with significant of niche composition. deploying and including downstream and Here we lot with to YieldXX the and share this There’s yield economics. we milestone oils. next area, for with and agreements with market ore anticipate oil of ag a CXXXX [ph] We majors a agreements We companies downstream is to in CXXXX participation in traits to and
larger companies of number space. Here partners ag types of the and in than handful the seed commodity much is potential
support and our involves two to revenue provide for more layering communications. to – combinations turn based service With we programs. and scientists To grants investor an plan the update for have Kristi to the government to We call for we platforms, over The technology this the in our of ongoing accessed on platform provide to progress. capability path plant discovery the accelerate R&D platforms, innovation access I’d on plan crop integration to this expand Kristi? future date, provide our partner-funded with leading relationships third by R&D technology like that, we on improvements of on sector. color where predict this and to can gene
